Zyprexa news | Breaking Zyprexa news | Zyprexa

Earnings Snapshots: Drug makers fare well in fourth quarter

... In the U.S., sales for the popular anti-psychotic decreased 15 percent because of slacking demand for the medication.

Worldwide, Fourth-quarter reports compiled from wire services * Peabody Energy Corp., the largest U.S.

coal producer, said net income rose to $162.2 million, or $1.21 a share, from $67.9 million, or 51 cents, a year earlier.

* Consol Energy Inc., the third biggest, said fourth-quarter profit surged as record demand from utilities raised prices for the power-plant fuel.

Profit at Pittsburgh-based Consol climbed to $87.6 million, or 94 cents a share, from $67.7 million, or 74 cents.

* United Parcel Service Inc.

said fourth-quarter profit rose 21 percent as the company transported more goods worldwide.

Net income increased to $1.05 billion, or 95 cents a share, from $866 million, or 76 cents, a year earlier.

Sales rose 22 percent to $12 billion from $9.84 billion.

* AT&T Inc., in its first earnings report since the combination of SBC Communications Inc.

and AT&T Corp., said net income rose to $1.66 billion, or 46 cents a share, from $688 million, or 21 cents, a year Advertisement earlier.

Sales gained 26 percent to $13 billion.

* Dow Chemical Co.

said profit rose 6.8 percent in the fourth quarter as prices ...

Plea possible in Dyer infanticide case

...<< Previous Story: S'ville ice arena could face zoning hurdles Archives Copyright © 1996-2006 nwitimes.com.

Reproduction or redistribution of content is expressly forbidden without the express written consent of nwitimes.com.

Privacy Policy Do Not Call Policy Ethics Policy ...

Amgen Inc. earnings rise 20 per cent while Eli Lilly and Co. ...

...In the U.S., sales for the popular anti-psychotic decreased 15 per cent because of slacking demand for the medication.

Worldwide, Other products fared better.

Sales of osteoporosis medication Forteo increased 59 per cent to $118 million, erectile dysfunction drug Cialis increased 38 per cent and four diabetes drugs climbed 11 per cent to a combined $750 million.

"Lilly is determined to be a leader in diabetes care," said Jim Ward, Lilly's executive director of investor relations.

Excluding certain charges in 2004 and 2005, as well as stock-option expensing in 2004, Lilly's earnings for the latest quarter would have risen to 80 cents per share, compared with 69 cents per share in the prior year.

Analysts polled by Thomson Financial expected earnings of 78 cents per share on $3.9 billion in sales.

For the full year, the company earned $1.98 billion, or $1.81 per share, versus $1.81 billion, or $1.66 a share, a year ago.

Sales rose to $14.65 billion from $13.86 billion.

Eli Lilly said it expects 2006 earnings of 73 cents to 75 cents per share for the first quarter and $3.10 to $3.20 per share for the year, with full-year sales up seven per cent to nine per cent.

Lilly shares fell eight cents to $57.09 in late trading on the New York Stock Exchange.

View more heart and stroke news PrintForwardBookmarkFeedbackTell us what you think!

...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news

Medicine   Health and Fitness